Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Oxazepam 604751

 

CASRN: 604-75-1

Formula: C15-H11-Cl-N2-O2

Synonyms/Common Names

  • 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl- (9CI)

Short-Term Toxicity

  • 13 weeks (Dosed-Feed)  (C62453)  Completed 
    • Mice: B6C3F1; Mice: Swiss Webster
    • Dose: TWO MICE STRAINS: 0, 0.0625, 0.125, 0.25, 0.5, OR 1%.

Long-Term Carcinogenicity

  • 2 years (Dosed-Feed)  (C62453)  Completed 
    • TR-443 (NIH Number: 93-3359)  (Peer Review Approval 12/01/1992A )
      Toxicology and Carcinogenesis Studies of Oxazepam in Swiss-Webster and B6C3F1 Mice (Feed Studies)
    • Mice: B6C3F1; Mice: Swiss Webster
    • Carcinogenesis Results
      • Male Mice Clear Evidence 
      • Female Mice Clear Evidence 
    • Dose: SW: 0, 2500, OR 5000; B6: 0, 125, 2500, OR 5000 PPM; 60/GROUP.
  • 2 years (Dosed-Feed)  (C62453B)  Completed 
    • TR-468 (NIH Number: 99-3958)  (Peer Review Approval 12/11/1996A )
      Toxicology and Carcinogenesis Studies of Oxazepam in F344/N Rats (Feed Studies)
    • Rats: F344/N
    • Carcinogenesis Results
      • Male Rats Equivocal Evidence 
      • Female Rats No Evidence 
    • Dose: 0, 625, 1250, 2500, 5000, OR 10000 PPM; 50/SEX/GROUP.

Special Studies

  • Absorption Distribution Metabolism Excretion (Dosed-Feed; Intravenous)  (S0765)  Completed 
    • Citation: Demby KB, Griffin RJ, Burka LT. The pharmacokinetics and biliary excretion of oxazepam in the F344 rat following 0, 14, and 28 days of exposure in the diet. The Toxicologist. 1993 Mar;13(1).
    • Rats: F344/N; Male Rats: Fischer 344
    • Dose: 2500 ppm (0, 14, 28 days repeat dose). 5 mg/kg.
  • Cell Proliferation (Dosed-Feed)  (S0205)  Completed 
    • Citation: Cunningham ML, Maronpot RR, Thompson M, Bucher JR. Early responses of the liver of B6C3F1 mice to the hepatocarcinogen oxazepam. Toxicol Appl Pharmacol. 1994 Jan;124(1):31-8.Pubmed Abstract
    • Male Rats: F344/N; Male Mice: B6C3F1
    • Dose: 25, 125, 2500, 5000 ppm [R,M].
  • Cell Proliferation (Dosed-Feed)  (S0639)  Completed 
    • Citation: Cunningham ML, Bucher JR. Pharmacodynamic responses of F344 rats to the mouse hepatocarcinogen oxazepam in a 90-day feed study. Toxicol Appl Pharmacol. 1998 Mar;149(1):41-8.Pubmed Abstract
    • Male Rats: F344/N
    • Dose: 5000 ppm.
  • Metabolism (Gavage)  (S0751)  Completed 
    • Citation: Griffin RJ, Burka LT. Metabolism and elimination of oxazepam in F344 rats. Drug Metab Dispos. 1995 Feb;23(2):232-9.Pubmed Abstract
    • Male and Female Rats: F344/N
    • Dose: 25, 250, 500 mg/kg.
  • Metabolism (Dosed-Feed)  (S0752)  Completed 
    • Citation: Griffin RJ, Burka LT, Cunningham ML. Activity of hepatic drug metabolizing enzymes following oxazepam-dosed feed treatment in B6C3F1 mice. Toxicol Lett. 1995 Apr;76(3):251-6.Pubmed Abstract
    • Male Mice: B6C3F1
    • Dose: 0, 125, 2500 ppm.
  • Metabolism (Gavage)  (S0753)  Completed 
    • Citation: Griffin RJ, Burka LT. Metabolism and elimination of oxazepam in B6C3F1 and Swiss-Webster mice. Drug Metabol Dispo. 1993; 21(5):918-926.Pubmed Abstract
    • Male and Female Mice: B6C3F1; Male and Female Mice: Swiss Webster
    • Dose: 25, 250 & 500 mg/kg.
  • Metabolism  (S0754)  Completed 
    • Citation: Griffin RJ, Burka LT, Demby KB. Oxidative biotransformation of oxazepam to reactive and nonreactive products in rat, mouse and human microsomes. Hum Exp Toxicol. 1995 Oct;14(10):779-86.Pubmed Abstract
    • Rats; Mice: B6C3F1; Human (Cell Lines)
  • Toxicokinetic Study (Gavage; Intravenous; Gavage; Intravenous; Gavage; Intravenous)  (S0301)  Completed 
    • Citation: Yuan J, Goehl TJ, Hong L, Clark J, Murrill E, Moore R. Toxicokinetics of oxazepam in rats and mice. J Pharm Sci. 1994 Oct;83(10):1373-9.Pubmed Abstract
    • Male and Female Rats: F344/N; Male and Female Mice: B6C3F1; Male and Female Mice: Swiss Webster
    • Dose: 20 mg/kg bwt [R,M]. 50, 200, 400 mg/kg bwt [R,M].
  • Toxicokinetic Study (Dosed-Feed)  (S0578)  Completed 
    • Male and Female Rats: F344/N
    • Dose: 625, 1250, 2500, 5000 or 10000 ppm.

Genetic Toxicology

  • In Vitro Cytogenetics (CA/SCE)  (785473)  Completed 
    • Sister Chromatid Exchange Negative 
    • Chromosome Aberrations Negative 
  • Micronucleus  (A98656)  Completed 
    • Citation: Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. Micronucleated Erythrocyte Frequency in Peripheral Blood of B6C3F1 Mice from Short-Term, Prechronic, and Chronic Studies of the NTP Carcinogenesis Bioassay Program. Environ. Molec. Mutagen. Vol. 36 (2000) 163-194
    • Mice: B6C3F1
    • Male Negative 
    • Female Negative 
  • Salmonella  (307396)  Completed 
    •  Negative